Albert Labs' Pre-Clinical Analytical and Toxicological Research Supports Company's Forthcoming Studies Pharmaceutical Investing
Knight Therapeutics and Helsinn Healthcare SA Enter into Exclusive License, Distribution, and Supply Agreement for Akynzeo® and Aloxi® Pharmaceutical Investing
New Two-Year Deucravacitinib Data Reinforce Durable Efficacy and Consistent Safety Profile in Treatment of Moderate to Severe Plaque Psoriasis Pharmaceutical Investing
Knight to Present at the 2022 RBC Capital Markets Global Healthcare Conference in New York City Pharmaceutical Investing
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Volta Inc. of Class Action Lawsuit and Upcoming Deadline - VLTA; VLTA WS Pharmaceutical Investing
BELLUS Health Reports First Quarter 2022 Financial Results and Business Highlights Pharmaceutical Investing
ABBV Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of June 6, 2022 Deadline in Securities Fraud Class Action Lawsuit Against AbbVie, Inc. Pharmaceutical Investing
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Biohaven Pharmaceutical Holding Co. Ltd. Buyout Life Science Investing News
CLASS ACTION UPDATE for ABBV, BKKT and MULN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
CLASS ACTION UPDATE for IBM, SDIG and AUPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
